Contact us

Investigational Medicinal Products Training

Dates

Times

4 days

Location

In-Person - York, United Kingdom

Availability

About This Course

As a QP or quality assurance professional working in this challenging area, are you aware of the current and planned changes around the manufacture of investigational medicinal products (IMPs)? This highly interactive IMP training course makes sure you are up to date.

Our course focuses on the quality systems and the Good Manufacturing Practice (GMP)/Good Clinical Practice (GCP) interface from the QP or quality leader’s perspective. More specifically, the QP’s duties and challenges in protecting trials, volunteers and patients. Led by former IMP expert inspectors, QPs and current consultants, this course adds value to QPs, auditors and those working in clinical trial supply.

This course is delivered in person at a hotel venue in York, UK.

This investigational medicinal products course is approved by the Royal Society of Chemistry as suitable for their members’ continuing professional development.


CPD Hours: 24 hours

NSF's GMP for Clinical Trials Manufacture and Supply course can be used as an alternative to this training if you're working towards gaining QP eligibility and this course's dates and/or delivery method are not suitable. Courses cover the same core content. View dates.

Key Learning Objectives

On completion of our IMP training course delegates will know and understand:

  • The regulations and requirements for the IMP QP, as well as upcoming changes
  • The requirements of the IMP module in the UK QP study guide
  • What regulators and inspectors look for
  • Where to focus audits of IMP operations on behalf of a QP
  • QP duties around IMPs and the GMPs relevant to IMPs

Course Outline

The Clinical Trial

  • The phases of clinical trials
  • Impact of trial design on manufacturing and packing operations

Regulatory Framework

  • Annex 13 and Clinical Trial Regulation 536/2014
  • GMP Regulation 2017/1569 for IMPs

Role of the Qualified Person

  • The legal duties
  • Key documentation, e.g. the Clinical Trial Authorisation (CTA), IMP dossier and product specification file
  • Control and certification of products manufactured or sourced outside the European Union
  • The two-stage release process
  • The role of the QP in split manufacture and in virtual companies
  • Special challenges

Good Manufacturing Practice

  • Sourcing of materials, including comparators
  • Production and quality control of IMPs
  • Packaging issues (labelling, blinding and product security)
  • Validation (how much, how soon?)
  • Assigning and extending shelf life
  • Retains and returns
  • Assessing “equivalence” of GMP standards

Good Clinical Practice

  • What is GCP?
  • The GMP/GCP interface (when do the responsibilities of the QP end?)

Discussion and Working Groups

A significant portion of course time is devoted to group work. Using case studies, delegates have the opportunity to put theory into practice. In addition, discussion periods (which include a course tutor panel session) provide delegates with an opportunity to obtain answers to their specific question and concerns.

Who Should Attend

The Aspiring Qualified Person

  • Our training is generally considered the best available and our QPs are held in high regard in the industry
  • As well as being accepted in the UK, our training courses are well known and accepted by several other EU countries including Ireland, the Netherlands, Austria, Hungary and Malta
  • You are more likely to become a QP with us than with any other training provider

The Pharmaceutical Technical Professional

  • Not all the people attending these courses intend to become QPs. Many use the training to develop as technical managers in other areas of pharmaceutical manufacture and control
  • Many industry professionals from a range of disciplines attend the courses as part of their continuing professional development. Taken with some of our other QP modules, this course is designed to lead to postgraduate certificate, diploma and MSc qualifications

Course Tutors

Course tutors will be selected from the following:

Richard Funnell - Richard spent 11 years with the MHRA, including seven as a Senior GMP Inspector with the lead for IMPs. Richard has current knowledge and understanding of what inspectors are looking for in the lead-up to the new clinical trial regulation being implemented.

Darren Jones - Darren is an ex-MHRA GMP Inspector and has audited dosage forms for both commercial and clinical trial applications. Darren also has a wealth of practical knowledge and experience applying GMP in the clinical development world gained during his 18 years with AstraZeneca, prior to joining the MHRA. He was a QP for IMPs and knows the real challenges and how to overcome them.

Kate Krachai – Kate is eligible to act as a QP and has over 20 years’ experience in the pharmaceutical industry across key positions in quality management and as a pharma lead auditor. Kate has extensive experience in pharmaceutical development, manufacture and supply of marketed and investigational medicinal products (IMPs) and the associated pharma quality system.

Catherine Kay - Catherine is eligible to act as a QP and has gained experience in both quality assurance and operational roles within the pharmaceutical industry, where she was responsible for the start-up of a new solid dose manufacturing and packaging facility.

Discounts

Multi-delegate discounts available. Discounts also offered to NHS staff and charities.

Qualified Person Training With NSF

Watch the video
  • I found the delivery by the tutors, the knowledge of the guest speakers and the course materials to be of a very high standard.
    Ming Ng / Forest Laboratories, Republic of Ireland
  • Very good course. Just the correct level of detail and complexity. A good mix of regulations and the science.
    Steve Evans
    Cycle Pharmaceuticals, UK
  • Excellent mix of theory, buzz groups and guest speakers. Feel a lot more knowledgeable on this subject now.
    Marie Robinson
    Novartis Vaccines & Diagnostics, UK

Additional Recommended Courses

Pharmaceutical Quality Systems
Virtual Classroom Training
Analysis and Testing

This highly focused, intensive four-and-a-half-day course, taught by leading scientists and former Quality Control Managers, is designed to provide the aspiring Qualified Person or pharmaceutical quality professional with the knowledge and understanding they need to be able to perform their duties with skill and competence when interacting with the Quality Control laboratories.

We will explain to you the strengths and limitations of analysis and specific analytical methods, we will advise you on how to apply the principles of quality management and GMP to the testing environment in a pragmatic, effective way, and we will advise you of the very latest “hot topics” with the regulators and how to ensure that your laboratories are in compliance.

This virtual blended training course will be delivered via a combination of an instructor-led virtual classroom and self-paced learning online. This will require an element of learning to be completed prior to the virtual classroom, as well as afterwards and this will be managed through our online Learning Management System. Full details, including timings for the instructor-led virtual classrooms, will be emailed following registration.

Tutors: Dave Waddington, Oona McPolin

Price: £3555 excluding VAT (where applicable)

Course registrations will close 5 working days before the start of the course.

You can view our booking terms and conditions from here.

Multiple Delegate Discounts are available for delegates from the same company attending the same course.
The first delegate must pay full price. The second delegate will receive a 20% discount. The third and any subsequent delegates will receive a 50% discount. Charities, NHS staff are entitled to a 50% discount. (Proof will be required).

Virtual Classroom Training
Pharmaceutical Microbiology
Virtual Classroom Training